Clearstead Advisors Portfolio holdings
Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$95.3M |
| 2 |
Gorman-Rupp
GRC
|
+$36.6M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$27M |
| 4 |
SpaceX
SPCX
|
+$23.1M |
| 5 |
iShares Gold Trust
IAU
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Global Equity ETF
CGGE
|
+$34.4M |
| 2 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$29.9M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$22.8M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$22.8M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$22.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.02% |
| 2 | Technology | 12.85% |
| 3 | Industrials | 7.3% |
| 4 | Financials | 5.21% |
| 5 | Consumer Discretionary | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
Openlane
OPLN
$4.17B
| $854 | ﹤0.01% |
25
+6
| +32% | +$222 |
2026 Q2
1 quarter
|
|
2702
Bakkt Inc
BKKT
$194M
| $852 | ﹤0.01% |
109
-9
| -8% | -$71 |
2025 Q3
4 quarters
|
|
2703
Range Nuclear Renaissance Index ETF
NUKZ
$581M
| $851 | ﹤0.01% |
14
| – | – |
2025 Q4
3 quarters
|
|
2704
Cardiff Oncology
CRDF
$61.9M
| $847 | ﹤0.01% |
700
| – | – |
2024 Q2
9 quarters
|
|
2705
1st Source
SRCE
$2.09B
| $845 | ﹤0.01% |
10
-3
| -23% | -$258 |
2026 Q2
1 quarter
|
|
2706
Bank of N.T. Butterfield & Son
NTB
$2.17B
| $844 | ﹤0.01% |
15
+1
| +7% | +$60 |
2021 Q1
22 quarters
|
|
2707
Origin Bancorp
OBK
$1.64B
| $836 | ﹤0.01% |
16
-13
| -45% | -$692 |
2026 Q2
1 quarter
|
|
2708
Shift4
FOUR
$3.47B
| $832 | ﹤0.01% |
23
| – | – |
2024 Q1
10 quarters
|
|
2709
Varex Imaging
VREX
$783M
| $831 | ﹤0.01% |
45
-7
| -13% | -$108 |
2026 Q2
1 quarter
|
|
2710
Acadia Pharmaceuticals
ACAD
$3.67B
| $827 | ﹤0.01% |
41
-991
| -96% | -$26.6K |
2020 Q1
26 quarters
|
|
2711
Balchem Corp
BCPC
$5.56B
| $825 | ﹤0.01% |
5
-6
| -55% | -$1.02K |
2026 Q2
1 quarter
|
|
2712
Burke & Herbert Financial Services Corp
BHRB
$1.41B
| $824 | ﹤0.01% |
12
| – | – |
2026 Q2
1 quarter
|
|
2713
Enact Holdings
ACT
$6.38B
| $822 | ﹤0.01% |
19
| – | – |
2026 Q2
1 quarter
|
|
2714
Boston Beer
SAM
$2.24B
| $821 | ﹤0.01% |
5
-30
| -86% | -$5.32K |
2025 Q2
5 quarters
|
|
2715
HNI Corp
HNI
$3.42B
| $816 | ﹤0.01% |
18
| – | – |
2026 Q2
1 quarter
|
|
2716
MaxLinear
MXL
$4.46B
| $814 | ﹤0.01% |
9
+8
| +800% | +$606 |
2026 Q2
1 quarter
|
|
2717
NCR Atleos
NATL
$3.49B
| $814 | ﹤0.01% |
18
+12
| +200% | +$555 |
2026 Q2
1 quarter
|
|
2718
AdvisorShares Pure US Cannabis ETF
MSOS
$786M
| $809 | ﹤0.01% |
179
| – | – |
2022 Q4
15 quarters
|
|
2719
Knife River
KNF
$3.2B
| $807 | ﹤0.01% |
16
-43
| -73% | -$2.92K |
2024 Q3
8 quarters
|
|
2720
Alumis Inc
ALMS
$780M
| $799 | ﹤0.01% |
+108
| New | +$2.24K |
2026 Q3
0 quarters
|
|
2721
Virtus Investment Partners
VRTS
$843M
| $794 | ﹤0.01% |
6
-23
| -79% | -$3.6K |
2026 Q2
1 quarter
|
|
2722
TSS Inc
TSSI
$189M
| $779 | ﹤0.01% |
80
+1
| +1% | +$10 |
2026 Q2
1 quarter
|
|
2723
Apple Hospitality REIT
APLE
$4.46B
| $776 | ﹤0.01% |
48
-55
| -53% | -$892 |
2026 Q2
1 quarter
|
|
2724
Rayonier
RYN
$6.38B
| $772 | ﹤0.01% |
42
-3,969
| -99% | -$83.1K |
2024 Q2
9 quarters
|
|
2725
iShares MSCI Spain ETF
EWP
$1.99B
| $770 | ﹤0.01% |
13
| – | – |
2025 Q4
3 quarters
|
|
Similar funds
Clearstead Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Clearstead Advisors held 3,935 positions worth $10.8B, up 1.9% from $10.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Clearstead Advisors's Q3 2026 filing shows 268 new, 1,353 increased, 1,363 reduced and 421 closed positions. Its largest new stake was Criteo S.A.: 105,734 shares worth $1.61M. The largest sale was Capital Group Global Equity ETF, an estimated $34.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q3 2026 buy was Criteo S.A.: 105,734 shares worth $1.61M.
- Clearstead Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2026, an estimated $95.3M increase.
- Clearstead Advisors's biggest Q3 2026 reduction was Capital Group Global Equity ETF, cutting an estimated $34.4M.
- Clearstead Advisors fully exited iShares 0-5 Year High Yield Corporate Bond ETF in Q3 2026, selling an estimated $11.5M.
- Clearstead Advisors's ten largest holdings make up 30% of its $10.8B portfolio in Q3 2026.
- Clearstead Advisors opened 268 new positions and closed 421 in Q3 2026.
- Clearstead Advisors's portfolio value rose 1.9% quarter-over-quarter to $10.8B.
Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.